PT3354280T - Formulações estabilizadas que contêm anticorpos anti-recetor de interleucina-4 (il-4r) - Google Patents

Formulações estabilizadas que contêm anticorpos anti-recetor de interleucina-4 (il-4r)

Info

Publication number
PT3354280T
PT3354280T PT181612888T PT18161288T PT3354280T PT 3354280 T PT3354280 T PT 3354280T PT 181612888 T PT181612888 T PT 181612888T PT 18161288 T PT18161288 T PT 18161288T PT 3354280 T PT3354280 T PT 3354280T
Authority
PT
Portugal
Prior art keywords
interleukin
antibodies
receptor
formulations containing
containing anti
Prior art date
Application number
PT181612888T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of PT3354280T publication Critical patent/PT3354280T/pt

Links

PT181612888T 2010-10-06 2011-10-05 Formulações estabilizadas que contêm anticorpos anti-recetor de interleucina-4 (il-4r) PT3354280T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39028310P 2010-10-06 2010-10-06

Publications (1)

Publication Number Publication Date
PT3354280T true PT3354280T (pt) 2020-09-01

Family

ID=45995014

Family Applications (1)

Application Number Title Priority Date Filing Date
PT181612888T PT3354280T (pt) 2010-10-06 2011-10-05 Formulações estabilizadas que contêm anticorpos anti-recetor de interleucina-4 (il-4r)

Country Status (13)

Country Link
AR (1) AR083338A1 (sr)
DK (2) DK2624865T3 (sr)
ES (2) ES2687813T3 (sr)
HK (1) HK1258305A1 (sr)
HR (1) HRP20181822T1 (sr)
HU (1) HUE052089T2 (sr)
LT (1) LT2624865T (sr)
PT (1) PT3354280T (sr)
RS (1) RS57850B1 (sr)
SI (1) SI2624865T1 (sr)
TW (7) TWI690329B (sr)
UA (1) UA111731C2 (sr)
UY (1) UY33652A (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR092177A1 (es) 2012-08-21 2015-03-25 Sanofi Sa Metodos para tratar o prevenir asma administrando un antagonista de il-4r
KR20230066127A (ko) * 2013-06-21 2023-05-12 사노피 바이오테크놀로지 Il-4r 길항제를 투여함에 의한 비용종증의 치료 방법
HUE046410T2 (hu) * 2013-06-21 2020-03-30 Sanofi Biotechnology Eljárások orrpolipózis kezelésére IL-4R-antagonista beadásával
KR20170081262A (ko) 2014-11-14 2017-07-11 사노피 바이오테크놀로지 Il-4r 길항제의 투여에 의한, 비용종을 동반한 만성 부비동염의 치료 방법
KR20200081429A (ko) 2017-10-30 2020-07-07 사노피 바이오테크놀로지, 소시에떼 빠르 악씨옹 셍쁠리피에 Il-4r 길항제를 투여하여 천식을 치료 또는 예방하는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
ES2332082B1 (es) * 2008-07-24 2010-10-26 Consejo Superior De Investigaciones Cientificas (Csic) 45% Sistema de alineacion de patrones en un sustrato mediante litografia por estencil.
WO2010029664A1 (ja) * 2008-09-10 2010-03-18 日本エクスラン工業株式会社 架橋アクリレート系繊維およびその製造方法
AU2010221156A1 (en) * 2009-03-06 2011-09-22 Genentech, Inc. Antibody formulation

Also Published As

Publication number Publication date
DK3354280T3 (da) 2020-09-28
TW201716086A (zh) 2017-05-16
TWI718890B (zh) 2021-02-11
UA111731C2 (uk) 2016-06-10
TWI782325B (zh) 2022-11-01
DK2624865T3 (en) 2018-10-22
SI2624865T1 (sl) 2018-10-30
TWI568445B (zh) 2017-02-01
TW201542229A (zh) 2015-11-16
ES2687813T3 (es) 2018-10-29
TW201221141A (en) 2012-06-01
TW201924718A (zh) 2019-07-01
LT2624865T (lt) 2018-10-25
ES2820246T3 (es) 2021-04-20
HRP20181822T1 (hr) 2018-12-28
UY33652A (es) 2012-04-30
RS57850B1 (sr) 2018-12-31
HUE052089T2 (hu) 2021-04-28
TWI690329B (zh) 2020-04-11
TWI498121B (zh) 2015-09-01
TW202320851A (zh) 2023-06-01
TW202102262A (zh) 2021-01-16
TW202026011A (zh) 2020-07-16
AR083338A1 (es) 2013-02-21
HK1258305A1 (zh) 2019-11-08
TWI679988B (zh) 2019-12-21

Similar Documents

Publication Publication Date Title
IL283424A (en) Stabilized formulations that include antibodies against the interleukin receptor (IL-4R)
HRP20181821T1 (hr) Stabilizirani pripravci koji sadrže anti-interleukin-6 receptorska (il-6r) antitijela
IL265501A (en) Stabilized liquid formulations containing antibody
HRP20170983T1 (hr) Pripravci s visokom koncentracijom antitijela
SI3409289T1 (sl) Stabilni sestavki, ki vsebujejo protitelo
HK1258305A1 (zh) 含有抗白介素-4受體(il-4r)的抗體的穩定製劑
EP2588141A4 (en) ANTIBODY FORMULATIONS